Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) Shares outstanding
Solventum Corporation's shares outstanding at the end of fiscal 2025 was $175.3M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $173.3M. Solventum Corporation ranks 11th of 51 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $175.3M | 0.92% |
| FY2024 | $173.7M | 0.58% |
| FY2023 | $172.7M | 0.00% |
| FY2022 | $172.7M | — |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $173.3M | (1.25%) |
| Mar 2026 | $175.5M | 0.11% |
| Dec 2025 | $175.3M | (0.06%) |
| Sep 2025 | $175.4M | 0.11% |
| 10 more quarters | Free account |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $677.2M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation | $173.3M |
| ALGN Align Technology, Inc. compare | $71.5M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| ATR AptarGroup, Inc. compare | $64.2M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on SOLV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Book value per share
- Revenue growth
- The full statement